This page shows the latest lebrikizumab news and features for those working in and with pharma, biotech and healthcare.
Almirall has announced that its IL-13 inhibitor lebrikizumab has been recommended by the European Medicines Agency’s human medicines committee to treat moderate-to-severe atopic dermatitis. ... and nearly 70% of patients receiving lebrikizumab combined
corticosteroids, showed that up 73% of patients treated with lebrikizumab experienced improvement or clearance of face or hand dermatitis. ... and commercialisation of lebrikizumab in the US and the rest of the world.
In clinical trials, patients experienced significantly clearer skin and less interference with sleep due to itch when taking lebrikizumab compared to placebo. ... development and commercialisation of lebrikizumab in the US and the rest of the world.
This approval] marks the first step of the regulatory process in Europe of lebrikizumab, which we believe has the potential to become a best-in-class treatment for AD. ... and commercialisation of lebrikizumab in the US and the rest of the world, but not
These studies are part of the clinical development programme for lebrikizumab in AD, assessing over 2, 000 patients. ... Patients involved in the two trials who were treated with lebrikizumab for a year continued to have relief from itching.
a 75% reduction in disease severity at 16 weeks when receiving lebrikizumab monotherapy in the programme. ... The safety profile of the 16-week period was consistent with prior lebrikizumab studies in atopic dermatitis.
More from news
Approximately 8 fully matching, plus 14 partially matching documents found.
This brings a much needed boost to its respiratory portfolio, which currently consists of Pulmozyme (cystic fibrosis) and Xolair (severe asthma) and products in clinical development, eg lebrikizumab (severe asthma).
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
No results were found
Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ of experience, Innovative Trials deploys...